BACKGROUND: Pyomyositis due to Escherichia coli (E. coil) is rarely reported in immunocompromised patients with hematological malignancy. CASE REPORT: We present a case report of a 34-year-old man who developed E. coli pyomyositis as a complication of acute myelogenous leukemia (AML). Magnetic resonance imaging (MRI) of the right hip suggested myofascial infection of the gluteal muscles, and a needle muscle aspiration grew E. coli phylogenetic group B2. The patient responded to intravenous piperacillin/tazobactam followed by prolonged oral levofloxacin. CONCLUSION: Pyomyositis should be suspected in all immunocompromised patients complaining of muscle pain and may exhibit signs of localized muscle infection. Appropriate antibiotic therapy targeting fluoroquinolone-resistant E. coli should be considered for initial empiric therapy of pyomyositis in immunocompromised patients.
BACKGROUND:Pyomyositis due to Escherichia coli (E. coil) is rarely reported in immunocompromised patients with hematological malignancy. CASE REPORT: We present a case report of a 34-year-old man who developed E. coli pyomyositis as a complication of acute myelogenous leukemia (AML). Magnetic resonance imaging (MRI) of the right hip suggested myofascial infection of the gluteal muscles, and a needle muscle aspiration grew E. coli phylogenetic group B2. The patient responded to intravenous piperacillin/tazobactam followed by prolonged oral levofloxacin. CONCLUSION:Pyomyositis should be suspected in all immunocompromised patients complaining of muscle pain and may exhibit signs of localized muscle infection. Appropriate antibiotic therapy targeting fluoroquinolone-resistant E. coli should be considered for initial empiric therapy of pyomyositis in immunocompromised patients.
Authors: L A Cone; R B Lamb; A Graff-Radford; J Rudder; S A Bach; J A Hirschberg; J F Feller; R A Lynch Journal: Clin Infect Dis Date: 1997-07 Impact factor: 9.079
Authors: Karen J Vigil; James R Johnson; Brian D Johnston; Dimitrios P Kontoyiannis; Victor E Mulanovich; Issam I Raad; Herbert L Dupont; Javier A Adachi Journal: Clin Infect Dis Date: 2010-02-01 Impact factor: 9.079
Authors: William R Schwan; Adam Briska; Buffy Stahl; Trevor K Wagner; Emily Zentz; John Henkhaus; Steven D Lovrich; William A Agger; Steven M Callister; Brian DuChateau; Colin W Dykes Journal: Microbiology (Reading) Date: 2010-04-08 Impact factor: 2.777
Authors: M Gousseff; F Lanternier; A Ferroni; O Chandesris; N Mahlaoui; O Hermine; O Lortholary; M Lecuit Journal: Eur J Clin Microbiol Infect Dis Date: 2013-02-01 Impact factor: 3.267
Authors: Migla Miskinyte; Ana Sousa; Ricardo S Ramiro; Jorge A Moura de Sousa; Jerzy Kotlinowski; Iris Caramalho; Sara Magalhães; Miguel P Soares; Isabel Gordo Journal: PLoS Pathog Date: 2013-12-12 Impact factor: 6.823